Clinical Trial Update: Acetylsalicylic Acid and Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating acetylsalicylic acid (aspirin) in Type 2 diabetes has completed, with the study examining its relation to the antioxidant enzyme syst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Centro Universitario de Ciencias de la Salud, Mexico | Conditions: Diabetes Mellitus, Type 2, Antioxidant Enzyme System | Phase 3 | Status: COMPLETED